INTRODUCTION {#SEC1}
============

Chemical modification of cellular DNA can have serious biological consequences including cytotoxicity, mutagenesis, carcinogenesis, neurodegeneration and aging ([@B1]--[@B8]). The chemical structure of a DNA lesion ultimately determines the exact nature of the dysfunction it causes. Thus, careful chemical structure determination is a critical step in the overall characterization of any particular DNA lesion. Rigorous chemical structure determination of DNA adducts typically requires spectroscopic characterization of the lesion ([@B9]). This may involve direct characterization of the lesion in, or released from, duplex DNA ([@B10]--[@B14]). Alternately, a synthetic standard of the putative lesion can be prepared and spectroscopically compared to the authentic lesion released from duplex DNA by enzymatic digestion ([@B9],[@B15]--[@B19]).

We recently reported a new type of interstrand DNA--DNA cross-link formed by reaction of a DNA abasic site (Ap site) with a 2′-deoxyadenosine (dA) residue on the opposing strand of the double helix ([@B20]). These interstrand cross-links form in high yields (15--70%) at 5′ApT/5′AA sequences in duplex DNA. In our earlier work, we proposed that formation of dA-Ap cross-links involved reaction of the exocyclic *N*^6^-amino group of 2′-deoxyadenosine with the aldehyde residue of the Ap site to generate a cyclic aminoglycoside (**4**, Scheme [1](#F9){ref-type="fig"}) ([@B21]--[@B24]). Digestion of double-stranded DNA containing the dA-Ap cross-link with a mixture of nuclease P1, alkaline phosphatase and phosphodiesterases I and II released a nucleoside cross-link 'remnant'; however, the precise chemical connectivity of the dA-Ap cross-link was not rigorously established.

![Proposed formation mechanism and structure of the dA-Ap cross-link in duplex DNA.](gkv174fig9){#F9}

Here we set out to characterize the chemical structure and properties of the dA-Ap cross-link generated in duplex DNA. Our experimental strategy involved characterization of the cross-link remnant released by enzymatic digestion of DNA duplexes containing the dA-Ap cross-link. We first synthesized an authentic standard of the putative nucleoside cross-link remnant **6** by reaction of dA with 2-deoxyribose (Scheme [2](#F10){ref-type="fig"}). Complete spectroscopic structure elucidation of this synthetic material rigorously established that the anomeric center of the 2-deoxyribose adduct was connected to the exocyclic *N*^6^-amino group of dA and showed that the compound exists as an equilibrating mixture of the α-pyranose, β-pyranose, α-furanose and β-furanose isomers. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) experiments demonstrated that the properties of the authentic cross-link remnant released by enzymatic digestion of DNA duplexes containing the dA-Ap cross-link matched those of the synthetic material **6**. Overall, these findings established the chemical structure of the dA-Ap cross-link released from duplex DNA and provide a means for the detection of this lesion in cellular DNA. We examined the chemical stability of the cross-link attachment in both the nucleoside remnant (**6**) and in duplex DNA. The cross-link remnant **6** was very stable at neutral pH, decomposing to release unmodified dA with a half-life of 65 days at 37°C. In DNA, the dA-Ap cross-link dissociated with half-lives of 84 and 66 h in duplexes **A** and **B**, respectively. The stability of the dA-Ap cross-link in duplex DNA forecasts the potential for this lesion to block the action of DNA processing enzymes involved in transcription and replication.

![Synthesis of the cross-link remnant **6**.](gkv174fig10){#F10}

MATERIALS AND METHODS {#SEC2}
=====================

Reagents and equipment {#SEC2-1}
----------------------

Oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA, USA), uracil DNA glycosylase (UDG, 5000 units/ml) and UDG buffer were purchased from New England Biolabs (Ipswich, MA, USA), 2′-deoxyadenosine (dA) monohydrate was purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan) and 2-deoxy-[d]{.smallcaps}-ribose (99%) was purchased from Sigma-Aldrich (St. Louis, MO, USA). HPLC grade methanol, dichloromethane and H~2~O were purchased from Fisher. All other reagents used were purchased from Acros Organics in reagent grade. Flash column chromatography was performed on silica gel 60 (Sigma-Aldrich). Glass-backed silica gel thin-layer chromatography (TLC) plates impregnated with fluorescent indicator were purchased from Sigma-Aldrich and stored in a desiccator. Compounds were visualized on developed TLC plates by their absorbance using a 254-nm UV lamp or by staining with a solution of 1% KMnO~4~. Nuclear magnetic resonance (NMR) spectra were obtained using a Bruker Avance 800 MHz at 298 K in DMSO-(*d~6~*) or D~2~O (Cambridge Isotope Laboratories, Inc., Cambridge, MA, USA).

Preparation of cross-linked DNA duplexes {#SEC2-2}
----------------------------------------

DNA duplexes containing Ap sites at defined locations were prepared using standard procedures ([@B25],[@B26]). The 2′-deoxyoligonucleotides (4 nmol) were placed in 150 μl of MOPS buffer (25 mM, pH 7) containing NaCl (100 mM). The duplexes **A** and **B** were annealed by warming the 2′-deoxyuridine-containing oligonucleotide samples to 95°C for 5 min with 3 equivalents of their respective complementary strands, followed by slow-cooling to room temperature overnight in an insulated container. Ap sites were generated by incubation of the DNA duplexes **A** or **B** with UDG (4 μl, 400 units/ml) in a mixture composed of UDG buffer (30 μl) and H~2~O (96 μl) at 37°C for 2 h. Following incubation, UDG was removed by phenol/chloroform extraction. DNA in the aqueous layer was precipitated by mixing with 10% v/v of 3-M aqueous sodium acetate buffer (pH 5.2), followed by 5 vol of absolute ethanol, cooling in dry ice (20 min) and centrifugation for 30 min at 5°C to precipitate the DNA. The pellets were washed twice with 80% ethanol-H~2~O (2 × 180 μl) and resuspended in H~2~O (100 μl). The cross-linking reaction was carried out at 37°C for 120 h in HEPES buffer (50 mM, pH 7.0) containing NaCl (100 mM). After incubation, DNA in the samples was precipitated as described above and loaded onto a 2-mm thick, 20% denaturing polyacrylamide gel and electrophoresed at 200 V for 4 h. The slow-moving, cross-link band was visualized by UV-shadowing and excised from the gel. The gel slice was crushed and the DNA eluted by agitation in 1 ml of aqueous NaCl (200 mM) containing ethylenediaminetetraacetic acid (1 mM, pH 8) for 1 h. The DNA-containing solution was filtered to remove gel fragments, the DNA precipitated, washed and stored at --20°C.

Enzymatic digestion of cross-linked duplexes {#SEC2-3}
--------------------------------------------

Duplexes **A** and **B** were digested using a 4-enzyme cocktail following the procedures described previously ([@B20],[@B27],[@B28]). Briefly, nuclease P1 (5 U), phosphodiesterase 2 (0.01 U), *erythro*-9-(2-hydroxy-3-nonyl)adenine (EHNA, 20 nmol) and a 50-μl solution containing 300-mM sodium acetate (pH 5.6) and 10-mM zinc chloride were added to 300 pmol of duplexes **A** or **B** in a final volume of 500 μl. In this context, EHNA served to inhibit the deamination of 2′-deoxyadenosine (dA) to 2′-deoxyinosine (dI) that can be caused by adenine deaminase impurities in the digestive enzymes ([@B20],[@B27],[@B28]). The resulting mixture was incubated at 37°C for 48 h. To the digestion mixture were then added alkaline phosphatase (10 U), phosphodiesterase 1 (0.005 U) and 100 μl of 0.5-M Tris-HCl buffer (pH 8.9) and the digestion continued at 37°C for 2 h. Digestion with nuclease P1 alone was performed according to published procedures ([@B20],[@B27],[@B28]), where nuclease P1 (0.2 U) was added to 300 pmol of cross-linked duplex in 500 μl of water. The resulting mixture was incubated at 37°C for 2 h. The enzymatic digestion mixture was extracted with chloroform to remove enzymes, the aqueous layer dried on a Speed-vac, the sample reconstituted in water and subjected to LC-MS/MS analyses ([@B20],[@B27],[@B28]).

*N*^6^-(2-deoxy-[d]{.smallcaps}-ribos-1-yl)-2′-deoxyadenosine (**6**) {#SEC2-4}
---------------------------------------------------------------------

The compounds 2′-deoxyadenosine monohydrate (154 mg, 0.57 mmol) and 2-deoxy-[d]{.smallcaps}-ribose (351 mg, 2.62 mmol) were dissolved in glacial acetic acid (300 μl) and methanol (700 μl). This solvent mixture was used previously for the construction of *N*-aryl aminoglycoside bonds in the synthesis of spicamycin analogs ([@B29]). The mixture was incubated at 37°C for 72 h, solvent removed under reduced pressure and the resulting residue subjected to column chromatography on silica gel eluted with a gradient of 5--12% methanol in dichloromethane. The fractions containing product were combined, dried under reduced pressure and evaporated from CDCl~3~ (3 × 2 ml) to yield **6** (115 mg, 54% yield) as a white powder. ^1^H NMR (800 MHz, D~2~O) δ 8.29 (0.63H, s, H8), 8.29 (0.29 H, s, H8), 8.28 (0.08H, s, H8), 8.26 (0.29H, s, H2), 8.25 (0.55H, s, H2), 8.25 (0.08H, s, H2), 8.24 (0.08H, s, H2), 6.43 (1H, t, *J* = 6.9 Hz, dR1), 6.28 (0.08H, br s, H1″), 6.21 (0.08H, br s, H1″), 5.81 (0.29H, brs, H1″), 5.48 (0.55H, brs, H1″), 4.64 (1H, m, H3′), 4.47 (0.08H, m, H3″), 4.44 (0.08H, m, H3″), 4.29 (0.29H, m, H3″), 4.17 (1H, m, H4′), 4.10 (0.08H, m, H4″), 4.07 (0.55H, m, H3″), 4.02 (0.08H, m, H4″), 3.94 (0.55H, m, H5″), 3.90 (0.84H, m, H4″), 3.84 (0.29H, m, H5″), 3.83 (1H, m, H5′), 3.79 (0.55H, m, H5″), 3.77 (1H, m, H5′), 3.76 (0.29H, m, H5″), 3.70 (0.08H, m, H5″), 3.69 (0.08H, m, H5″), 3.65 (0.08H, m, H5″), 3.64 (0.08H, m, H5″), 2.80 (1H, m, H2′), 2.66 (0.08H, m, H2″), 2.55 (1H, m, H2′), 2.39 (0.08H, m, H2″), 2.33 (0.08H, m, H2″), 2.24 (0.29H, m, H2″), 2.16 (0.08H, m, H2″), 2.13 (0.55H, m, H2″), 2.08 (0.29H, m, H2″), 2.07 (0.55H, m, H2″); ^13^C NMR (200 MHz, D~2~O) δ 156.1 (C6), 156.0 (C6), 155.9 (C6), 154.9 (C2), 154.8 (C2), 154.8 (C2), 154.7 (C2), 151.3 (C4), 143.5 (C8), 143.3 (C8), 122.2 (C5), 122.1 (C5), 122.0 (C5), 90.1 (C4′), 90.1 (C4′), 88.6 (C4″), 87.9 (C4″), 87.4 (C1′), 87.3 (C1′), 88.6 (C1″), 80.3 (C1″), 77.9 (C1″), 74.3 (C3″), 73.9 (C3′), 73.8 (C3″), 70.3 (C3″), 69.6 (C5″), 69.3 (C4″), 69.2 (C4″), 68.5 (C3″), 66.1 (C5″), 64.7 (C5″), 64.4 (C5′), 63.9 (C5″), 41.7 (C2″), 41.7 (C2′), 41.6 (C2″), 37.1 (C2″), 35.6 (C2″).

*N*^6^-\[3,5-bis-*O*-methyl-2-deoxy-[d]{.smallcaps}-ribofuranos-1-yl\]-2′-deoxyadenosine (**7**) {#SEC2-5}
------------------------------------------------------------------------------------------------

A mixture of 3,5-bis-*O*-methyl-2-deoxy-[d]{.smallcaps}-ribofuranose ([@B30],[@B31]) (263 mg, 1.62 mmol) and 2′-deoxyadenosine (100 mg, 0.40 mmol) was dissolved in 2 ml of a 1:1 (v/v) mixture of ammonium phosphate buffer (25 mM, pH 7) and DMSO, stirred at 37°C for 9 days and the mixture evaporated to yield a yellow oil. Column chromatography on silica gel eluted with a gradient of 0--5% methanol in CH~2~Cl~2~ gave **7** as a colorless oil (22 mg, 14%): ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 8.45--8.39 (1H, m, H8), 8.35--8.00 (1.5H, m, H2, *N*^2^-H), 7.55 (0.5H, brs, *N*^2^-H), 6.40--6.33 (1H, m, H1′), 6.24 (1H, brs, H1″), 5.35 (1H, brs, 3′-OH), 5.23--5.08 (1H, m, 5′-OH), 4.41 (1H, brs, H3′), 4.07 (0.5H, q, *J* = 4.3, H4″), 3.94--3.89 (0.5H, m, H4″), 3.89--3.85 (1H, m, H4′), 3.85--3.81 (1H, m, H3″), 3.64--3.58 (1H, m, H5a′), 3.55--3.48 (1H, m, H5b′), 3.36--3.30 (3.5H, m, H5″, *O*-C[H]{.ul}~3~), 3.26 (1.5H, s, *O*-C[H]{.ul}~3~), 3.25 (1.5H, s, *O*-C[H]{.ul}~3~), 3.24 (1.5H, s, *O*-C[H]{.ul}~3~), 2.71 (1H, ddd, *J* = 13.4, 6.6, 6.6, H2a′), 2.43--2.33 (0.5H, m, H2a″), 2.33--2.22 (1.5H, m, H2b′, H2a″), 2.20--2.08 (1H, m, H2b″); ^13^C NMR (126 MHz, DMSO-*d*~6~) δ 153.5 (C6), 152.1 (C2), 149.1 (C4), 140.3, 140.1 (C8), 119.6 (C5), 88.0 (C4′), 83.8 (C1′), 81.7 (C3″), 81.5 (C3″), 80.9 (C4″), 80.6 (C4″, C1″), 73.3, 72.8 (C5″), 70.8 (C3′), 61.8, 61.7 (C5′), 58.5, 56.8, 56.0 (*O*-[C]{.ul}H~3~), 39.4, (C2′), 35.8 (C2″). TOF MS(ES+): 396.1881.

*N*^6^-\[1-deoxo-2-deoxy-3,5-bis-*O*-methyl-[d]{.smallcaps}-ribofuranos-1-yl\]-2′-deoxyadenosine (**8**) {#SEC2-6}
--------------------------------------------------------------------------------------------------------

Compound **7** (18 mg, 0.05 mmol), NaBH~3~CN (100 mg, 1.6 mmol) and acetic acid (25 μl, 0.4 mmol) were dissolved in dry methanol (5 ml). The mixture was warmed to 40°C and stirred for 48 h, at which time additional portions of NaBH~3~CN and acetic acid were added (200 mg, 3.2 mmol and 50 μl, 0.8 mmol, respectively). After 68 h, the reaction was mixed with saturated aqueous Na~2~CO~3~ (5 ml) and the resulting suspension lyophilized. The resulting residue was brought back up in methanol, filtered to remove solids and the filtrate evaporated to give a colorless oil. Column chromatography on silica gel eluted first with ethyl acetate and then with CH~2~Cl~2~-methanol (9:1) gave **8** as a colorless oil (8 mg, 44%, *R*~f~ = 0.21 in 9:1 CH~2~Cl~2~-methanol): ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 8.32 (1H, s, H8), 8.20 (1H, s, H2), 7.80 (1H, brs, *N*-H), 6.34 (1H, dd, *J* = 7.5, 6.5, H1′), 5.31 (1H, d, *J* = 3, 3′-OH), 5.25 (1H, t, *J* = 5.25, 5′-OH), 4.81 (1H, brs, 4″-OH), 4.43--4.38 (1H, m, H3′), 3.88 (1H, q, *J* = 3.3, H4′), 3.67--3.59 (2H, m, H4″, H5a′), 3.59--3.48 (3H, m H1″, H5b′), 3.37--3.31 (1H, m, H5a″), 3.29 (3H, s, *O*-C[H]{.ul}~3~), 3.28--3.25 (1H, m, H5b″), 3.23 (3H, s, *O*-C[H]{.ul}~3~) 3.22--3.18 (1H, m, H3″), 2.72 (1H, ddd, *J* = 13.1, 6.6, 6.6, H2a′), 2.25 (1H, ddd, *J* = 13.1, 6.1, 2.6, H2b′), 1.90--1.81 (1H, m, H2a″), 1.77--1.66 (1H, m, H2b″); ^13^C NMR (126 MHz, DMSO-*d*~6~) δ 154.6 (C6), 152.4 (C2), 148.0 (C4), 139.3 (C8), 119.7 (C5), 88.0 (C4′), 84.0 (C1′), 79.8 (C3″), 74.0 (C5″), 71.0 (C3′), 70.2 (C4″), 61.9 (C5′), 58.3, 57.3 (*O*-[C]{.ul}H~3~), 39.4 (C2′), 36.8 (C1″), 29.6 (C2″). TOF MS(ES+): 398.2034.

Analysis of the stability of **6** {#SEC2-7}
----------------------------------

Compound **6** was dissolved in sodium phosphate buffer (100 mM, pH 7.0) to give a final concentration of 5 mM and a final volume of 8 ml. The solution was incubated at 37°C and aliquots (300 μl) were removed at specific time points and analyzed by HPLC employing a Varian Microsorb-MV C18 (250 × 4.6 mm) column eluted with water (solvent A) and acetonitrile (solvent B) in the following gradient: 0--5 min 0% B, 5--50 min 0--18% B, 50--55 min 18--0% B and 55--60 min 0% B. Products were detected by their absorbance at 250 nm.

RESULTS AND DISCUSSION {#SEC3}
======================

Synthesis and spectroscopic characterizations of the cross-link remnant **6** {#SEC3-1}
-----------------------------------------------------------------------------

The putative cross-link remnant **6** was prepared by reaction of 2′-deoxyadenosine (0.6 M) with 2-deoxy-[d]{.smallcaps}-ribose (2.6 M) in a solvent mixture-composed methanol-acetic acid (2:1 v/v; Scheme [2](#F10){ref-type="fig"}). Thin layer chromatographic analysis of the reaction mixture on silica gel revealed formation of a single new polar spot. Column chromatography gave the product in 54% yield.

Proton NMR analysis revealed resonances for both dA and an additional 2-deoxyribose unit consistent with the anticipated structure **6** (Tables S1 and S2). The HMQC spectra allowed assignment of carbon-to-hydrogen connectivity. Multiple resonances were observed for the 2-deoxyribose adduct in the product. This was not unexpected, as 2-deoxyribose itself exists as an equilibrium mixture of the α-pyranose, β-pyranose, α-furanose and β-furanose isomers (Scheme [2](#F10){ref-type="fig"}) ([@B32]). Similarly, *N*-aryl-2-deoxyaminoriboside analogs exist as a mixture of cyclic forms, in which the pyranose isomers typically dominate ([@B21],[@B33]--[@B36]). Thus, the observation of multiple resonances for the carbons and hydrogens of the 2-deoxyribose unit in the product suggested that the adduct was present as an equilibrium mixture of four possible isomers (α-pyranose, β-pyranose, α-furanose and β-furanose). A 2D-EXSY-NMR experiment that gives cross-peaks between sites that are in slow chemical exchange confirmed that the multiple resonances reflected an equilibrium mixture of 2-deoxyribose isomers in the product. For example, the H1″ signals from 5.6--6.3 ppm are a dynamic isomeric mixture of four separate signals (Figure [1](#F1){ref-type="fig"}).

![EXSY-2D-NMR of the H1″ spectral region for compound **6**. Correlations between the isomers of **6** appear as contours at the intersecting lines between signals for the H1″ protons, indicating a dynamic equilibrium between the α-pyranose, β-pyranose, α-furanose and β-furanose isomers of the 2-deoxyribose adduct located at the exocyclic *N*^6^-amino group of the adenine residue.](gkv174fig1){#F1}

The 2-deoxyribose adduct in **6** has the potential to exist as a ring-opened imine, carbinolamine or a cyclic hydroxyalkylhemiaminal. The observed chemical shifts of the of 75--82 ppm for C1″ are consistent with the cyclic structures **6** ([@B35]). The NMR data provided no evidence for imine, carbinolamine or enamine functional groups in the product. The NMR results further suggest that the α-pyranose isomer predominates in solution. This is supported by observation that C4″ in the major isomer displays a chemical shift of 69 ppm ([@B35]) and the presence in this isomer of correlations between the C5″ hydrogens and the C1″ carbon in the HMBC experiment. The major isomer showed a strong NOE cross-peak between the H1″ and H3″, consistent with the α-isomer (Figure [2](#F2){ref-type="fig"}). The ratio of isomers in water was ∼7:4:1:1 (Supplementary Figure S10) which is similar to the ratio of isomers reported for unsubstituted 2-deoxy sugars ([@B37]).

![NOESY spectrum of the H1″ resonances of compound **6**. The correlations between the 3″ and 1″ protons suggest that resonances B and D are α-anomers. The absence of this correlation suggests that resonance C is from the β-anomer.](gkv174fig2){#F2}

The NMR data provided evidence that the anomeric carbon of the 2-deoxyribose adduct was attached at the exocyclic *N*^6^-amino group of the 2′-deoxyadenosine unit, as shown in structure **6**. For example, an ^15^N-HMBC experiment revealed three-bond coupling between the *N*^6^-nitrogen and the H2″ protons of the 2-deoxyribose adduct (Figure [3](#F3){ref-type="fig"}). Furthermore, the TOCSY spectra showed that the *N*^6^-H, the H1″ and H2″ protons reside in the same spin system (Figure [4](#F4){ref-type="fig"}). Overall, the NMR analysis established that the reaction of dA with 2-deoxyribose provided the desired cross-link remnant **6**.

![^15^*N*-HMBC data showing the H2″ spectral region of compound **6**. The correlations between *N*^6^ of dA and H2″ of dR can be seen by contours shown at the intersecting lines between signals for the *N*^6^ and H2″ protons, indicating a two to three-bond coupling between these atoms.](gkv174fig3){#F3}

![TOCSY data showing the *N*^6^-H correlations with H1″ protons of compound **6**. The correlations between the *N*^6^-H of dA and H1″ of dR can be seen by contours shown at the intersecting lines between signals for the *N*^6^-H and H1″ protons, indicating these protons are in the same spin system.](gkv174fig4){#F4}

Stability of the dA-dR cross-link remnant 6 and the dA-Ap cross-link in duplex DNA {#SEC3-2}
----------------------------------------------------------------------------------

Before endeavoring to use the synthetic cross-link remnant **6** as an analytical standard, we examined the chemical stability of this material. Compound **6** can be classified broadly as an *N*-aryl glycosylamine. Compounds of this type have the potential to undergo hydrolytic decomposition to release the free sugar and the unmodified arylamine ([@B38]--[@B40]). We used HPLC to examine the stability of **6** in sodium phosphate buffer (50 mM, pH 7) at both 37 and 75°C. First, we noted that all four isomers of **6** described above in the context of the NMR experiments could be resolved by reversed-phase HPLC (Figure [5](#F5){ref-type="fig"}). Second, we found that the synthetic cross-link remnant **6** was remarkably stable, decomposing to release unmodified dA with a half-life of 65 days at 37°C and 3 days at 75°C (Figure [6](#F6){ref-type="fig"}).

![HPLC chromatogram panels for the dissociation of compound **6** at 75°C in 20 mM sodium phosphate (pH 7.0). Peak 1 is 2′-deoxyadenosine, peaks 2 and 4 are major isomers of compound **6** while peaks 3 and 5 are minor isomers of compound **6**. k~37°C~ = 1.05 ± 0.02 × 10^--2^ d^-1^, k~75°C~ = 2.41 ± 0.01 × 10^--1^ d^-1^ (estimated E~a~ = 74 kJ/mol or 18 kcal/mol).](gkv174fig5){#F5}

![Decomposition of compound **6** (falling curve) at 75°C into 2-deoxyribose and dA (rising curve). HPLC analysis of the products (UV 250 nm) was used to observe the disappearance of **6** and the appearance of dA. The solid lines represent a nonlinear regression analysis fit to a first-order growth or decay process with k~75°C~ = 6.5 × 10^--3^ h^-1^.](gkv174fig6){#F6}

We also monitored the stability of the dA-Ap cross-link embedded within two different DNA duplexes (Figure [7](#F7){ref-type="fig"}). The 5′-^32^P-radiolabeled, cross-linked duplexes **A** and **B** were prepared as described previously ([@B20]), gel purified and then redissolved in HEPES buffer (50 mM, pH 7) containing NaCl (100 mM) and incubated at 37°C. At various times, aliquots were removed, frozen and later subjected to analysis by denaturing polyacrylamide gel electrophoresis (Figure [7](#F7){ref-type="fig"} and Supplementary Figure S20). The dA-Ap cross-links within duplexes **A** and **B** were quite stable, dissociating with half-lives of 66 and 85 h, respectively (Supplementary Figures S20 and S21), to give the Ap-containing oligonucleotide **1** (Scheme [1](#F9){ref-type="fig"}) and small amounts of the 3′-4-hydroxy-2-pentenal-5-phosphate cleavage product resulting from β-elimination at the Ap site ([@B1],[@B41],[@B42]). In a separate experiment, the amount of remaining cross-linked duplexes **A** and **B** was monitored after incubation at 22°C over the course of 96 h, in three different buffers with pH values of 5, 7, or 9. At pH 5, 25 and 40% dissociation of cross-linked duplexes **A** and **B**, respectively, into the component single strands was observed. No dissociation of the cross-linked duplexes **A** and **B** was observed over the course of 96 h at 22°C at pH 7 or 9 (Supplementary Figure S22).

![Above: cross-linked oligonucleotide duplexes used for enzymatic digestion and LC-MS/MS analysis and stability studies (duplexes used in mass spectrometric studies did not contain the ^32^P label). Location of the dA-Ap cross-links is indicated with the line (\\). Below: dissociation of the purified cross-link in duplex A incubated in 50 mM HEPES (pH 7.0) and 100 mM NaCl at 37°C for 0, 0.25, 1, 2, 5, 10, 15 and 21 days (lanes 1--8). Following incubation for the specified time, DNA in the samples was ethanol precipitated, washed and stored at --20°C until analysis by 20% denaturing gel electrophoresis. The amount of remaining cross-link at each time point was quantitatively measured by phosphorimager analysis.](gkv174fig7){#F7}

Evidence that the synthetic nucleoside cross-link remnant **6** matches the authentic remnant released by enzymatic digestion of DNA containing the dA-Ap cross-link {#SEC3-3}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

With a synthetic standard of the putative dA-Ap cross-link remnant **6** in hand, we used LC-MS/MS analysis to determine whether this synthetic material matched the actual remnant released from cross-linked DNA by enzymatic digestion. We have previously characterized formation of the dA-Ap cross-link in two different DNA sequence contexts, **A** and **B** (Figure [7](#F7){ref-type="fig"}) ([@B20]). These cross-linked duplexes (lacking the 5′-^32^P-label) were prepared, gel purified and treated with a four enzyme cocktail consisting of nuclease P1, alkaline phosphatase and phosphodiesterases I and II to release the cross-link remnant as previously described ([@B20]). A separate control experiment showed that the synthetic standard **6** was stable under the enzymatic digestion conditions (Supplementary Figure S18). The digested oligonucleotide mixtures and the synthetic material **6** were analyzed by LC-MS/MS and -MS/MS/MS, where we monitored the fragmentation of the \[M+H\]^+^ ion (*m/z* 368) of the cross-link remnant and the further fragmentation of the ion of *m/z* 252 observed in MS/MS, respectively. We found multiple peaks in the selected-ion chromatograms for monitoring the *m/z* 368→252 transition in MS/MS (for the loss of a 2-deoxyribose), and the *m/z* 368→252→136 transition (for the loss of another 2-deoxyribose) in MS/MS/MS. These results are consistent with aforementioned observations that the cross-link remnant exists as an equilibrium mixture of the α-pyranose, β-pyranose, α-furanose and β-furanose isomers that are separable by HPLC. Importantly, the retention times and fragmentation pattern of the synthetic material **6** matched that of the remnant released by enzymatic digestion of the cross-linked duplexes **A** and **B** (Figure [8](#F8){ref-type="fig"} and Supplementary Figure S19). These results provide evidence that the chemical connectivity of the dA-Ap cross-link is that shown in structure **6** (Scheme [2](#F10){ref-type="fig"}).

![LC-MS/MS and -MS/MS/MS of the synthetic standard **6** and the enzymatically digested cross-linked duplex B. Panels (**a**) and (**b**) are for the synthetic nucleoside **6**, while panels (**c**) and (**d**) show the cross-link remnant obtained from digestion of duplex B. Panels (a) and (c) are the selected-ion chromatograms for the *m*/*z* 368→252 transition. Panels (b) and (d) are the selected-ion chromatograms for the *m*/*z* 368→252→136 transition. Shown in the insets are the MS/MS ((a) and (c)) and MS/MS/MS ((b) and (d)) averaged from the 28.4-min fraction in (a) and (b), and 28.8-min fraction in (c) and (d).](gkv174fig8){#F8}

Chemical reduction of the cross-link remnant **6** {#SEC3-4}
--------------------------------------------------

As shown in Schemes [1](#F9){ref-type="fig"} and [2](#F10){ref-type="fig"}, the dA-Ap cross-link is an imine-derived lesion. While our NMR analysis provided evidence that the synthetic cross-link remnant **6** exists predominantly in the ring-closed form, equilibration of the isomers presumably proceeds via small amounts of the imine **5**. Similarly, the hydrolytic decomposition of **6** described above likely proceeds via attack of water on the presumptive imine intermediate **5**. Imine-derived adducts can be stabilized by reduction using reagents such as sodium cyanoborohydride ([@B43]--[@B47]). Accordingly, we examined whether the cross-link remnant **6** was a substrate for hydride reduction. Interestingly, we were not able to execute reduction of **6** using common hydride donors including sodium borohydride, sodium cyanoborohydride and sodium triacetoxyborohydride. Various solvent mixtures (methanol, water and acetic acid), solution pH values (3--7) and amounts of hydride donor (10--1000 equiv) were examined, but no new product could be detected by TLC, NMR or HPLC analysis. Greenberg *et al*. similarly found that a cross-link derived from the reaction of dA with 5′-(2-phosphoryl-1,4-dioxobutane) in duplex DNA was refractory to reduction by NaCNBH~3~ ([@B48]). We suspected that the equilibrium amounts of the reactive imine **5** might be too small to allow a reasonable rate of reduction. By way of analogy, there are examples in which the equilibrium amount of free, ring-opened aldehyde dictates the reaction rates of aldoses ([@B49]). To test this idea we synthesized an analog of the dA-dR cross-link remnant that cannot access the favored pyranose isomer due to protection of the 5′- and 3′-hydroxyl groups in the 2-deoxyribose adduct (**7**; Scheme [3](#F11){ref-type="fig"} and Supplementary Figures S12--S14). We anticipated that this analog might present a larger fraction of the reactive imine **5**. Indeed, we found that compound **7** can be converted, albeit rather slowly, to the reduced form **8** in 44% yield by reaction with NaCNBH~3~ (100 equiv) and acetic acid (∼ 2% v/v) at 40°C in methanol for 68 h (Scheme [3](#F11){ref-type="fig"} and Supplementary Figures S15--S17). Slow reduction of other aldehyde-derived imine adducts on DNA, including a formaldehyde adduct at *N*^6^-dA and FaPy-dG lesions, has been observed by others ([@B35],[@B50],[@B51]).

![Reduction of the 5′/3′-protected cross-link remnant **7**.](gkv174fig11){#F11}

CONCLUSIONS {#SEC4}
===========

This work was designed to shed light on the structure and properties of the dA-Ap cross-link formed in duplex DNA. We carried out a chemical synthesis and structure determination of the putative nucleoside cross-link remnant **6**. LC-MS analysis showed that the properties of the synthetic material matched that of the authentic remnant released from cross-linked DNA by enzymatic digestion. The results provided evidence that the dA-Ap cross-link involves attachment of the exocyclic *N*^6^-amino group of dA to the anomeric carbon of the Ap residue. In addition, our work provides methodology that can be applied to the detection of this cross-link lesion in cellular DNA.

Although the dA-Ap cross-link is an imine-derived lesion (Scheme [1](#F9){ref-type="fig"}), our spectroscopic evidence indicated that the 2-deoxyribose adduct exists as an equilibrium mixture of the α-pyranose, β-pyranose, α-furanose and β-furanose isomers. No evidence for the ring-opened imine or carbinolamine structures was observed. Cyclization of the sugar hydroxyl residue(s) may serve to mask the hydrolytically labile imine intermediate, thus stabilizing the dA-Ap cross-link. Both the nucleoside cross-link remnant and the cross-link in duplex DNA are stable for days at neutral pH. The stability of the dA-Ap cross-link suggests that this may be a persistent lesion with the potential to block the action of various DNA-binding and DNA-processing enzymes.
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